Log in
Enquire now
User profile

Karina Erakilyan

designer
Joined March 2022
18
Contributions
ContributionsActivity
Influencer marketingInfluencer marketing was edited byKarina Erakilyan profile picture
Karina Erakilyan
March 29, 2022 11:30 am
Topic thumbnail

Influencer marketing

Social media marketingSocial media marketing was edited byKarina Erakilyan profile picture
Karina Erakilyan
March 29, 2022 11:30 am
Topic thumbnail

Social media marketing

Use of social media platforms and websites to promote a product or service

Digital marketingDigital marketing was edited byKarina Erakilyan profile picture
Karina Erakilyan
March 29, 2022 11:29 am
Topic thumbnail

Digital marketing

Digital marketing, also called online marketing, is the promotion of brands to connect with potential customers using the internet and other forms of digital communication. This includes not only email, social media, and web-based advertising, but also text and multimedia messages as a marketing channel.

Leading KnowledgeLeading Knowledge was edited byKarina Erakilyan profile picture
Karina Erakilyan
March 29, 2022 11:28 am
Table  (+1 rows) (+3 cells) (+65 characters)

Name
Role
Social link

Alan Wunsche

Founder & CEO

https://www.linkedin.com/in/alanwunsche/

Leading KnowledgeLeading Knowledge was edited byKarina Erakilyan profile picture
Karina Erakilyan
March 29, 2022 11:28 am
Table  (+1 cells) (+28 characters)

Name
Role
Social link

Laura Pratt

Founder

https://angel.co/laura-pratt

‌
Deactivated Topic
was edited byKarina Erakilyan profile picture
Karina Erakilyan
March 29, 2022 11:27 am
Table  (+1 rows) (+5 cells) (+193 characters)

Title
Author
Link
Type
Date

Tilt Joins Y Combinator's Winter 2021 Batch | by Deepak VS | Tilt | Mar, 2021 | Tilt

Deepak VS

https://medium.com/tiltbike/tilt-joins-y-combinators-winter-2021-batch-3bcd2e314f0c

Web

March 20, 2021

MendelMendel was edited byKarina Erakilyan profile picture
Karina Erakilyan
March 29, 2022 11:26 am
Table  (+1 rows) (+3 cells) (+63 characters)

Name
Role
Social link

Alan Karpovsky

Founder

https://www.linkedin.com/in/alankarpovsky/

Mobile paymentMobile payment was edited byKarina Erakilyan profile picture
Karina Erakilyan
March 29, 2022 11:26 am
Topic thumbnail

Mobile payment

PaymentPayment was edited byKarina Erakilyan profile picture
Karina Erakilyan
March 29, 2022 11:25 am
Topic thumbnail

Payment

Transfer of an item of value from one party (such as a person or company) to another in exchange for the provision of goods, services or both, or to fulfill a legal obligation

VellarisVellaris was edited byKarina Erakilyan profile picture
Karina Erakilyan
March 29, 2022 11:24 am
Table  (+1 rows) (+3 cells) (+94 characters)

Name
Role
Social link

Adam Adamov

Founder & CEO

https://www.linkedin.com/in/adam-adamov-958b8335/?originalSubdomain=uk

Consumer biotechnologyConsumer biotechnology was edited byKarina Erakilyan profile picture
Karina Erakilyan
March 29, 2022 11:23 am
Table  (+1 rows) (+5 cells) (+180 characters)

Title
Author
Link
Type
Date

The 5 Wildest Biotech Products Of The Future - SOSV - Medium

Elsa Sotiriadis, PhD

https://medium.com/sosv/the-5-wildest-biotech-products-of-the-future-9ae20abd1ab9

Web

October 17, 2017

Consumer biotechnologyConsumer biotechnology was edited byKarina Erakilyan profile picture
Karina Erakilyan
March 29, 2022 11:23 am
Topic thumbnail

Consumer biotechnology

Contour TherapeuticsContour Therapeutics was edited byKarina Erakilyan profile picture
Karina Erakilyan
March 29, 2022 11:21 am
Table  (+1 rows) (+5 cells) (+361 characters)

Title
Author
Link
Type
Date

BridgeBio Pharma and Maze Therapeutics Establish Joint Venture to Advance Precision Medicine to Treat Cardiovascular Disease

BridgeBio Pharma, Inc.

https://www.globenewswire.com/news-release/2020/12/07/2140571/0/en/BridgeBio-Pharma-and-Maze-Therapeutics-Establish-Joint-Venture-to-Advance-Precision-Medicine-to-Treat-Cardiovascular-Disease.html

Web

December 7, 2020

Contour TherapeuticsContour Therapeutics was edited byKarina Erakilyan profile picture
Karina Erakilyan
March 29, 2022 11:19 am
Article  (+185 characters)

A joint venture between BridgeBio Pharma and Maze Therapeutics, focused on transforming and advancing breakthrough precision medicine approaches designed to treat cardiovascular disease

Contour TherapeuticsContour Therapeutics was edited byKarina Erakilyan profile picture
Karina Erakilyan
March 29, 2022 11:19 am
Topic thumbnail

Contour Therapeutics

Maze TherapeuticsMaze Therapeutics was edited byKarina Erakilyan profile picture
Karina Erakilyan
March 29, 2022 11:18 am
Table  (+1 rows) (+3 cells) (+55 characters)

Name
Role
Social link

Jonathan S. Weissman

Founder

https://mazetx.com/about-us/

‌
Jonathan S. Weissman
was edited byKarina Erakilyan profile picture
Karina Erakilyan
March 29, 2022 11:18 am
Infobox
Educated at
Whitehead Institute
Whitehead Institute
‌
Jonathan S. Weissman
was edited byKarina Erakilyan profile picture
Karina Erakilyan
March 29, 2022 11:18 am
Article  (+1756 characters)

Dr. Jonathan S. Weissman currently serves as professor of biology and member of the Whitehead Institute. He is also an investigator at the Howard Hughes Medical Institute and co-leads the Laboratory for Genomic Research, funded by GlaxoSmithKline, which drives development of CRISPR-based therapeutics. He also serves as chairman of the scientific advisory board for the Stowers Institute and serves on the scientific advisory board for Amgen and the Helen Hay Whitney Foundation. Prior to joining the Whitehead Institute, Jonathan held various faculty positions at the University of California, San Francisco, which culminated in his role as vice chair of the Department of Cellular & Molecular Pharmacology. Additionally, Jonathan is a co-founder of KSQ Therapeutics.

Jonathan is widely recognized for building innovative tools for broadly interrogating the organizational principals of biological systems. These include ribosome profiling for globally monitoring protein translation and the development of CRISPRi/a to enable fine-tuned modulating human gene expression at genome scale. He has received the Irving Sigal Young Investigator Award from the Protein Society, the Raymond and Beverly Sackler International Prize in Biophysics, the National Academy of Sciences Award for Scientific Discovery, and the Keith R. Porter Lecture Award from the American Society for Cell Biology. Jonathan is a member of the National Academy of Sciences.

Jonathan holds an A.B. in physics, summa cum laude, from Harvard College. After obtaining a Ph.D. in physics from the Massachusetts Institute of Technology, where he worked with Dr. Peter Kim, Jonathan pursued postdoctoral fellowship training in Arthur Horwich’s laboratory at Yale University School of Medicine.